| Literature DB >> 23434873 |
Xiao-Long Yang1, Zhuang-Zhuang Li.
Abstract
(-)-(4S, 8S)-Foedanolide (1a) andEntities:
Mesh:
Substances:
Year: 2013 PMID: 23434873 PMCID: PMC6269859 DOI: 10.3390/molecules18022236
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1The structures of compounds 1a and 1b.
1H- (600 MHz) and 13C-NMR (150 MHz) data for 1 in CDCl3.
| No. |
|
| No. |
|
|
|---|---|---|---|---|---|
| 1 | 176.0 (s) | 8 | 2.67 (t, 6.6) | 55.4 (d) | |
| 2 | 2.76 (t, 7.2) | 29.4 (t) | 9 | 1.85 (m), 1.38 (m) | 25.4 (t) |
| 3 | 2.30 (m), 2.16 (m) | 26.1 (t) | 10 | 1.65 (m), 1.38 (m) | 30.1 (t) |
| 4 | 92.1 (s) | 11 | 1.38 (m) | 22.9 (t) | |
| 5 | 163.9 (s) | 12 | 0.93 (t, 7.2) | 13.9 (q) | |
| 6 | 138.0 (s) | 13 | 2.01 (s) | 10.9 (q) | |
| 7 | 203.8 (s) | 14 | 1.76 (s) | 8.2 (q) |
Figure 2The 1H, 1H-COSY and selected HMBC correlations of 1.
Figure 3The structures of the two diastereomers, cis (4R,8S) and trans (4R,8R).
Figure 4(A) Experimental CD; (B) Computed CD for cis and trans isomers.
Antitumor effects of (−)-foedanolide (1a) and (+)-foedanolide (1b) (IC50, µg/mL).
| Compound | HeLa | A549 | U251 | HepG2 | MCF-7 |
|---|---|---|---|---|---|
| (-)-foedanolide ( | 15.8 | 296.0 | 159.0 | 22.8 | 70.2 |
| (+)-foedanolide ( | 5.4 | 67.9 | 53.0 | 19.0 | 20.8 |
| DPP(positive control) | 4.5 | 8.6 | 8.5 | 0.7 | 4.3 |